PYC Therapeutics Limited (ASX:PYC)
1.700
+0.140 (8.97%)
At close: Dec 24, 2025
PYC Therapeutics Market Cap
PYC Therapeutics has a market cap or net worth of 991.54 million as of December 26, 2025. Its market cap has increased by 40.26% in one year.
Market Cap
991.54M
Enterprise Value
839.95M
Revenue
23.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.70
Market Cap Chart
Since March 30, 2005, PYC Therapeutics's market cap has increased from 28.04M to 991.54M, an increase of 3,435.59%. That is a compound annual growth rate of 18.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 991.54M | 60.99% |
| Dec 31, 2024 | 615.92M | 50.00% |
| Dec 29, 2023 | 410.62M | 87.08% |
| Dec 30, 2022 | 219.48M | -48.89% |
| Dec 31, 2021 | 429.43M | -8.19% |
| Dec 31, 2020 | 467.71M | 157.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 84.74B |
| Pro Medicus | 24.25B |
| Cochlear | 17.13B |
| Sonic Healthcare | 11.15B |
| Ramsay Health Care | 8.09B |
| Ansell | 5.05B |
| Telix Pharmaceuticals | 4.04B |
| Mesoblast | 3.69B |